Generative design of antibody Fc-variants with synthetic and programmable functional profiles β
bioRxiv, 2025
Building AI systems at the intersection of AI and the life sciences.
I've spent 8 years building AI systems across research, engineering, and production. As a technical founder I took an AI initiative from zero to production, used daily by 100+ scientists β shipping LLM-powered tools and agent systems (agent architectures, context engineering, evaluation frameworks).
I work fluently across the model stack, from training and post-training to agentic systems, and I build alongside domain experts to turn hard research problems into reliable tools they actually adopt, with evaluation and trust built in.
Entrepreneurial and mission-driven, I care about making frontier AI safe and beneficial β in the hands of scientists, and for humanity.
Write a longer biography here β your background, education, roles and milestones. This can be a few paragraphs.
Add a second paragraph with more detail whenever you like.
bioRxiv, 2025
Briefings in Bioinformatics, 2025, NeurIPS 2024 Workshop on AI for New Drug Modalities
Frontiers in Robotics & AI, 2021
Companies I've founded, or support as an advisor or investor.
One line on what the company does β replace with your own.
One line on what the company does β replace with your own.
One line on what the company does β replace with your own.
October 2025
Artificial Intelligence in Dermatology Research and Drug Discovery
June 28, 2019
Greek Students Create Device that Stops Trembling of Parkinson's Patients
Month DD, YYYY
One-sentence description of the third media reference goes here.